UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 6, 2008

 

 

Oracle Healthcare Acquisition Corp.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   000-51785   26-0126028

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(I.R.S. Employer

Identification No.)

200 Greenwich Ave., 3rd Floor

Greenwich, Connecticut 06830

(Address of principal executive offices)

(203) 862-7900

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

 

x Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 8.01 Other Events.

Beginning February 6, 2008, Oracle Healthcare Acquisition Corp. (the “Company”) will hold meetings with certain investors regarding the proposed merger between PTI Acquisition Sub, Inc., a wholly owned subsidiary of the Company, and Precision Therapeutics, Inc. The presentation to be used in connection with such investor meetings is furnished as Exhibit 99.1 to this report.

 

Item 9.01 Financial Statements and Exhibits.

 

  (d) Exhibits

 

Exhibit No.

  

Description:

Exhibit 99.1    Investor Presentation

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ORACLE HEALTHCARE ACQUISITION CORP.
Date:  February 6, 2008   By:  

/s/ Joel D. Liffmann

  Name:   Joel D. Liffmann
  Title:   President and Chief Operating Officer

INDEX TO EXHIBITS

 

Exhibit No.

  

Description:

Exhibit 99.1

   Investor Presentation
Oracle Healthcare Acquis... (CE) (USOTC:OHAQ)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Oracle Healthcare Acquis... (CE) Charts.
Oracle Healthcare Acquis... (CE) (USOTC:OHAQ)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Oracle Healthcare Acquis... (CE) Charts.